Primary Site >> Liver Cancer
Gene >> CDKN3
| 1. | |||||||||||
| Journal: | Cancer Res. 2000 Sep 1;60(17):4697-700. | ||||||||||
| Title: | Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma. | ||||||||||
| Author: | Yeh, C T|Lu, S C|Chen, T C|Peng, C Y|Liaw, Y F | ||||||||||
| PMID: | 10987270 | ||||||||||
| 2. | |||||||||||
| Journal: | Int J Cancer. 2003 Jul 10;105(5):601-6. | ||||||||||
| Title: | Involvement of PKC betaII in anti-proliferating action of a new antitumor compound gnidimacrin. | ||||||||||
| Author: | Yoshida, Mitsuzi|Heike, Yuji|Ohno, Shigeo|Ikekawa, Tetsuro|Wakasugi, Hiro | ||||||||||
| PMID: | 12740906 | ||||||||||
| 3. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2003 May 30;305(2):311-4. | ||||||||||
| Title: | Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant. | ||||||||||
| Author: | Yeh, Chau-Ting|Lu, Su-Chuan|Chao, Chung-Hao|Chao, Mei-Ling | ||||||||||
| PMID: | 12745075 | ||||||||||
| 4. | |||||||||||
| Journal: | Cell Prolif. 2011 Jun;44(3):291-9. | ||||||||||
| Title: | Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation. | ||||||||||
| Author: | Wang, L|Sun, L|Huang, J|Jiang, M | ||||||||||
| PMID: | 21535270 | ||||||||||
| 5. | |||||||||||
| Journal: | J Toxicol Sci. 2011 Oct;36(5):613-23. | ||||||||||
| Title: | Altered expression of GADD45 genes during the development of chemical-mediated liver hypertrophy and liver tumor promotion in rats. | ||||||||||
| Author: | Ozawa, Shogo|Gamou, Toshie|Habano, Wataru|Inoue, Kaoru|Yoshida, Midori|Nishikawa, Akiyoshi|Nemoto, Kiyomitsu|Degawa, Masakuni | ||||||||||
| PMID: | 22008536 | ||||||||||
| 6. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2012 Mar 30;420(1):29-35. | ||||||||||
| Title: | Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation. | ||||||||||
| Author: | Xing, Chunyang|Xie, Haiyang|Zhou, Lin|Zhou, Wuhua|Zhang, Wu|Ding, Songming|Wei, Bajin|Yu, Xiaobo|Su, Rong|Zheng, Shusen | ||||||||||
| PMID: | 22390936 | ||||||||||
| 7. | |||||||||||
| Journal: | PLoS One. 2012;7(4):e35510. | ||||||||||
| Title: | Functional and topological properties in hepatocellular carcinoma transcriptome. | ||||||||||
| Author: | Drozdov, Ignat|Bornschein, Jan|Wex, Thomas|Valeyev, Najl V|Tsoka, Sophia|Malfertheiner, Peter | ||||||||||
| PMID: | 22539975 | ||||||||||
| 8. | |||||||||||
| Journal: | Oncol Rep. 2013 Mar;29(3):903-10. | ||||||||||
| Title: | Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth. | ||||||||||
| Author: | Lin, Wey-Ran|Lai, Ming-Wei|Yeh, Chau-Ting | ||||||||||
| PMID: | 23292002 | ||||||||||
| 9. | |||||||||||
| Journal: | Mol Med Rep. 2016 Aug;14(2):1509-14. | ||||||||||
| Title: | CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma. | ||||||||||
| Author: | Dai, Wei|Miao, Huilai|Fang, Shuo|Fang, Tao|Chen, Nianping|Li, Mingyi | ||||||||||
| PMID: | 27314282 | ||||||||||
| 10. | |||||||||||
| Journal: | Nutrients. 2017 Apr 29;9(5). pii: nu9050445. | ||||||||||
| Title: | Choline, Other Methyl-Donors and Epigenetics. | ||||||||||
| Author: | Zeisel, Steven | ||||||||||
| PMID: | 28468239 | ||||||||||
| 11. | |||||||||||
| Journal: | Onco Targets Ther. 2018 Apr 4;11:1861-1869. | ||||||||||
| Title: | Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis. | ||||||||||
| Author: | Zhou, Lei|Du, Yanyan|Kong, Lingqun|Zhang, Xingyuan|Chen, Qiangpu | ||||||||||
| PMID: | 29670361 | ||||||||||
| 12. | |||||||||||
| Journal: | Cancer Biomark. 2018;22(3):511-521. | ||||||||||
| Title: | Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches. | ||||||||||
| Author: | Zhang, Liang|Huang, Yi|Ling, Junjun|Zhuo, Wenlei|Yu, Zhen|Shao, Mengmeng|Luo, Yunbo|Zhu, Yi | ||||||||||
| PMID: | 29843214 | ||||||||||
| 13. | |||||||||||
| Journal: | World J Gastroenterol. 2018 Jun 28;24(24):2605-2616. | ||||||||||
| Title: | Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma. | ||||||||||
| Author: | Sang, Liang|Wang, Xue-Mei|Xu, Dong-Yang|Zhao, Wen-Jing | ||||||||||
| PMID: | 29962817 | ||||||||||